tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Twist Bioscience raises FY24 revenue view to $288M-$293M from $285M-$290M

Consensus $289.79M. Sees FY24 gross margin 40%-41%. Sees FY24 capital expenditure $15M.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on TWST:

Disclaimer & DisclosureReport an Issue

1